|
HS Code |
470955 |
| Cas Number | 107871-76-7 |
| Molecular Formula | C29H36O15 |
| Molecular Weight | 624.59 g/mol |
| Appearance | Yellow powder |
| Purity | ≥98% (HPLC) |
| Solubility | Soluble in methanol, DMSO, and ethanol |
| Source | Forsythia suspensa (plant origin) |
| Storage Temperature | -20°C, protected from light |
| Synonyms | Isoforsythiaside A |
| Iupac Name | (2R,3R,4S,5R,6R)-2-[4-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-3,5-dihydroxyphenyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
| Usage | Phytochemical research, standard reference |
As an accredited Isoforsythiaside factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Isoforsythiaside, 100 mg, is packaged in a sealed amber glass vial with tamper-evident cap, labeled for laboratory use. |
| Shipping | Isoforsythiaside is shipped in tightly sealed, chemical-resistant containers to ensure stability and prevent contamination. The packaging complies with international safety and regulatory guidelines. Suitable temperature and protection from light are maintained during transit. Shipping is conducted via certified couriers specializing in chemical logistics, with tracking and safety documentation included. |
| Storage | Isoforsythiaside should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible substances. It is recommended to keep it in a tightly sealed container at 2–8°C (refrigerated conditions). Protect from moisture and strong oxidizing agents. Label the container clearly and handle under appropriate laboratory safety protocols to prevent degradation and ensure safe handling. |
Competitive Isoforsythiaside prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Over the past decades working in natural product synthesis, we’ve seen a steady shift in research attention toward phenylethanoid glycosides. Isoforsythiaside has emerged from this landscape not through clever marketing, but through reproducible performance batch after batch. The conversation around phenylethanoids often circles back to forsythiaside A, credited in countless papers and cited in industry presentations worldwide. Our work with isoforsythiaside grew from requests for an alternative profile—one with a different isomeric structure and measurable differences in application behavior.
Handling isoforsythiaside at industrial scale gives an up-close view seldom available to bench-scale researchers. The physical and chemical properties aren’t identical to more well-known forsythiasides. During crystallization and purification, distinct temperature and solvent ratios come into play. We see sharper separation during HPLC purification and a noticeably higher chemical stability profile at mildly elevated storage temperatures. In our controlled stress tests, isoforsythiaside showed less degradation under light and oxidative conditions than its isomeric relatives, allowing for more confident downstream formulation.
In customer discussions, the first question often concerns purity and related substances, especially as many downstream users aim for oral or topical application. Through multi-step dynamic simulation, we developed a model (often referenced as Isoforsythiaside-FMP2023) that consistently delivers product at >98% purity by HPLC, without a lingering solvent residue. Physical appearance remains consistent: off-white to pale yellow crystalline powder, easily dispersible in water or ethanol. Particle size distribution is tightly controlled between batches by precisely regulated re-crystallization and de-agglomeration, a detail most apparent during scaling from pilot to several hundred kilogram lots.
Our clients in pharmaceuticals, cosmetics, and even veterinary health, each approach isoforsythiaside from their unique requirements. As a factory technician, I’ve seen formulators puzzle over extraction impurities that haunt traditional phenylethanoid glycosides. With our isoforsythiaside, the clean profile allows more accurate activity-screening without extra background signal. In topical delivery, labs often highlight the molecule’s improved photostability, which means shelf life doesn’t get eaten away under fluorescent lighting by the time the product ships cross-border.
Biologically, isoforsythiaside offers antioxidant and anti-inflammatory effects in early research. While as chemists, we leave pharmacological claims to clinicians, repeated customer feedback shows a pattern: clearer interpretability in bioassay results compared to more “mixed” phenylethanoid extracts. This makes sense—purity and absence of extractable plant impurities reduce background interference. In fine chemical terms, isoforsythiaside becomes the “known variable” in a series of complex experiments, rather than a wildcard with untraceable artifacts.
Every year we re-examine our process against forsythiaside A, verbascoside, and echinacoside—each with its following and limitations. Forsythiaside A, in particular, has a longer research track record, but struggles in stability testing performed in humid subtropical conditions. We compared the two by maintaining parallel lots at 30°C/60% RH for four months; isoforsythiaside retained over 93% original content, where forsythiaside A dropped close to 85%. Particle morphology also differs. Isoforsythiaside’s crystalline plates settle consistently and don’t readily form fines, cutting down on dusting in automated dispensers.
Verbascoside users sometimes require a more polar solvent system; isoforsythiaside processes easily in both water and mid-polarity alcohols. This creates flexibility when researchers design test matrices or multi-compound screens. Echinacoside, often pressed into cosmetic blends, carries a tendency to darken over time unless handled in strictly inert conditions. Isoforsythiaside, by contrast, shows stronger resistance to discoloration, helping maintain formulation appearance.
Our technical team operates cleanroom lines able to push annual capacity above five tons of isoforsythiaside, with in-process inspections at each crystallization checkpoint. Process reproducibility comes down to patience—watching crystal formation under microscope, adjusting solvent ratios in real time, and routinely running multiple filtrations to reach stringent color and bulk density standards. Lot release data offer a dry look at purity and identity, but for us, batch-to-batch thermal behavior matters just as much. No two harvests of forsythia raw material behave identically, but strict input controls and in-house analytics help stabilize the results.
Isoforsythiaside’s structure is well-characterized by NMR, MS, IR, and UV spectra, and every shipment leaves the factory with full analytical trace documentation. Customer audits—often accompanied by their own portable HPLC or TLC systems—help keep us sharp. We meet frequent requests for custom mesh sizes or solubility modifications, which requires us to carefully adjust crystallization times or post-processing drying conditions to avoid degradation or over-drying. Such field-driven tweaks never replace core GMP controls; they add flexibility for end-users with demanding equipment or formulation constraints.
Working directly with multinational R&D divisions means our staff gets a real-time pulse from people actually handling the product. In one case, a European skin-care manufacturer switched to isoforsythiaside after years battling variable stability with conventional phenylethanoids. Post-implementation, their QA team logged improved potency retention—confirmed across multiple continents and shipping routes. In pharmaceutical pilot runs, better solubility profiles translated to fewer filtration blockages. Our veterinary partners focused on consistency in color and reduced off-smell during blending—attributes easily overlooked on paper, but fundamental to product development.
We’ve responded to unexpected customer challenges, such as sudden regulatory inquiries into trace solvents or heavy metals, by integrating real-time mass spec monitoring into production. This hands-on adaptation shortens the gap between inspection and release, and allows customers with strict thresholds (for example, infant or ophthalmic uses) to pass audits with greater ease. Environmental standards in certain destinations set water content or residue benchmarks. As a manufacturer, direct process control offers the ability to meet these demands faster and more consistently than a trading reseller ever could.
Sourcing quality forsythia fruit is the backbone of isoforsythiaside production. In the past, we struggled with regional fluctuations in active constituent content, leading to frustrating inconsistencies. Years of hands-on fieldwork taught us which farms delivered predictable product and which didn’t invest in proper post-harvest drying. Through seasonal contract farming, we’ve established a pretty reliable supply base that supports predictable output. This gives us latitude to focus on the chemistry rather than constantly firefighting on sourcing.
By managing extraction, isolation, purification, and fill-finish all on site, we keep the timeline in check and reduce cross-contamination. Each step—right from initial maceration through to final micronization—can be adjusted in response to observed batch differences. For instance, during rainy years with wetter raw material, solvent volumes or extraction times need recalibration. Our lab teams use on-site analytics to make these calls, rather than waiting days for outside contract results to come back. Ultimately, in-house capacity means production continuity and quality don’t hinge on a distant supplier’s reliability.
Many industry customers express frustration at product drift: shipments that look identical on the COA but behave unpredictably in final use. Our team’s approach has always emphasized keeping production vertically integrated. Full process oversight lets us trace every lot of isoforsythiaside back through each process stage, down to the temperature and humidity logs for a particular shift. In moments where adjustments prove necessary, decision-making power stays with the manufacturing chemist, not a remote middleman. This prevents minor deviations from snowballing into disruptive product changes.
Direct manufacturing also enables faster adaptation to regulatory and environmental shifts. For example, adjusting to new guidelines on residual solvents took a single production cycle—instead of waiting months for policy updates to wend through the supply chain. As global standards keep tightening, the value of manufacturing agility only grows. Feedback loops between our QA team and external users move quickly, and necessary improvements are implemented within weeks, not quarters or fiscal years.
Years on the plant floor reveal that not every batch proceeds smoothly. During isoforsythiaside production, small pH shifts or missed time windows show up as clouding or off-pack color, especially during neutralization and solvent exchange. On paper this looks simple—but in practice, each batch tells its own story. Careful hand-on monitoring of viscosity, temperature, and batch color requires experienced operators. Often, the solution comes down to operator intuition built over long shifts—much more than any written guideline captures.
Scaling up from grams to tons, subtle factors surface: a difference in impeller design, or a one-degree shift in room temperature, suddenly impact yield and purity. Our technical leads invest time in training their teams to spot these variances early, before they dilute product quality. Investing in automated monitoring technology pays off in the long run—but the critical eye of a skilled human operator cannot be replaced. By working on-site and running direct pilot-to-production lineups, our staff ensures larger volumes don’t introduce hidden flaws.
Over the last few years, the regulatory landscape around plant-derived molecules has toughened. Auditors look closely at trace components, not just the headline compound. We’ve responded by revalidating our cleaning cycles, and tightening incoming raw material QC specs to cut down on potential co-extractives. Analytical platforms have moved from simple TLC and UV spec to full-spectrum mass spectrometry, NMR, and chiral HPLC. Each of these changes adds work, but as a manufacturer, staying compliant means more than meeting a passing grade—it means customers don’t face surprises in their own downstream audit cycles.
Research also pushes us: academic partners ask for material with verified batch consistency, while large commercial labs request data sharing and audit support. Our willingness to provide open access to batch data and sample retains has resulted in more trusted long-term partnerships. This transparency would be impossible without direct control over each manufacturing step. Requests for process validation or regulatory dossiers are routinely met from our on-site documentation—a point of difference that researchers value when planning long-term studies or product launches.
Balanced against technical progress, isoforsythiaside manufacturing comes with its fair share of practical hurdles. Raw material seasonality occasionally forces buffer stock building, which swells inventory costs and puts pressure on cold storage facilities. Sometimes a new crop introduces subtle differences in matrix content, requiring fast process reoptimization. Staff knowledge, built over years running these cycles, is what keeps production on track when unforeseen complications threaten a timely delivery.
Shipment logistics for high-purity isoforsythiaside present their own problems. During summer months, containers exposed to heat waves have shown minor changes in bulk density and off-odor, leading us to invest in better insulation and rapid transit options on popular shipping lanes. Customers in the southern hemisphere mail back physical samples for investigation, which helps us refine our internal SOPs and anticipate future market needs. This kind of closed loop—listening to feedback, making measurable adjustments, and preventing recurrences—comes about only with direct manufacturer involvement.
Demand for traceable, well-characterized plant molecules rises each year. Rather than simply following trends, we work shoulder-to-shoulder with end-users, research teams, and regulatory specialists, building direct lines of communication. This shapes the way we approach everything from process engineering to documentation standards. As global expectations evolve, so do our processes—always with the aim to deliver a dependable, application-ready isoforsythiaside.
Our story as manufacturers isn’t about selling a miracle product; it’s about listening to users, responding to laboratory and formulation realities, and building long-term confidence batch after batch. Isoforsythiaside became a mainstay in our catalog at the insistence of research-driven users looking for an alternative to existing phenylethanoid glycosides. Its unique chemical stability, clean synthetic profile, and real-world application advantages came to light during years of hands-on production, tight quality feedback, and process adaptation. That’s what readers should expect from direct factory support, and that’s the value we strive to maintain every day.